Gada Italia has signed a new distribution contract for the cardiovascular line. The new partner is Resuscitec GmbH, a spin-off company of the Medical Center – University of Freiburg (Germany).
Resuscitec’s flagship product is “CARL“, a smart technical concept for resuscitation after cardiac arrest. It was developed in an interdisciplinary collaboration between physicians and perfusionists at the Clinic for Cardiovascular Surgery at the Medical Center – University of Freiburg.
The CARL System is designed to improve survival and neurologic recovery in patients affected by cardiac arrest. It is based on the CARL Therapy, a novel therapeutic approach for resuscitation that emphasizes controlled, targeted and personalized whole-body reperfusion.
Learn more: https://resuscitec.de/